Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants
PurposePlasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We investigated the usefulness of serial BNP mea...
Main Authors: | Jeonghee Shin, Eun Hee Lee, Jee Hyun Lee, Byung Min Choi, Young Sook Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2017-06-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-60-175.pdf |
Similar Items
-
Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns
by: Laura Vargas Dornelles, et al.
Published: (2016-05-01) -
Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01) -
Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01) -
Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01) -
Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014-09-01)